Kultura Brands, Inc., today announced that 500,000,000 (five hundred million) common shares of its stock have been officially retired and removed from the company's issued and outstanding shares.
Read MoreThe Company holds $50M of cash and approximately 55M BERA, valued at $110M based on Binance's 24-hour VWAP for the period ending at 12:00 a.m. ET on October 23, 2025
Ben Isenberg appointed as Chief Investment Officer to manage the Berachain treasury strategy
Bruce Linton joins the board as Chairman, and Billy Levy joins as director
Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration
Read More
Electrovaya's 3 year growth percentage of 383%, ranking 3rd in the Enterprise-Industry Leaders category that is limited to enterprise-level companies with a minimum of C$50 million in revenue
Read More15-year exclusive license to deploy XCF's modular, scalable renewable fuel platform across Australia, targeting development of three renewable fuel production facilities
XCF to receive a 12.5%equity stake, licensing fees, and one board seat in New Rise Australia
Formalizes the June 2025 Memorandum of Understanding and launches the first regional platform under XCF's international expansion strategy
Major private-label win awarded by leading direct-to-consumer and top Amazon seller of high-quality natural nutritional supplements for women.
Specially formulated gummies designed to naturally support a woman's hormonal balance and overall health and well-being.
Gummy USA chosen among multiple competitors based on unique formulation and technology that delivers superior gummy texture and flavor-even with the most challenging ingredients.
Large follow-on order scheduled to ship within four weeks, keeping Healthy Extracts on track for another year of record revenue growth and profitability.
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
Read MoreNew findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.
Read More
